Millennium Management’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-176,327
Closed -$351K 6201
2025
Q2
$351K Buy
176,327
+21,543
+14% +$39.4K ﹤0.01% 5111
2025
Q1
$224K Sell
154,784
-257,036
-62% -$475K ﹤0.01% 5249
2024
Q4
$852K Buy
411,820
+153,815
+60% +$289K ﹤0.01% 4336
2024
Q3
$454K Sell
258,005
-231,970
-47% -$595K ﹤0.01% 4910
2024
Q2
$7.09M Sell
489,975
-186,591
-28% -$2.56M ﹤0.01% 2384
2024
Q1
$11.3M Buy
+676,566
New +$10.8M ﹤0.01% 2074
2022
Q3
Sell
-16,949
Closed -$185K 7230
2022
Q2
$185K Buy
+16,949
New +$201K ﹤0.01% 5674

Millennium Management's HLVX Position: Q3 2025 in Review

Millennium Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 176,327 shares — an estimated $351K sold.

Millennium Management first reported a position in HLVX in Q2 2022 and held it in 7 quarters. The position peaked at $11.3M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Millennium Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 176,327 HilleVax shares in Q3 2025, an estimated $351K.
  • Millennium Management first reported a position in HilleVax in Q2 2022 and held it in 7 quarters.
  • Millennium Management's HilleVax position peaked at $11.3M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.